New York, New York--(Newsfile Corp. - November 12, 2024) - The law firm of Kirby McInerney LLP reminds investors of the November 25, 2024 deadline to seek the role of lead plaintiff in a class action ...
New York, New York--(Newsfile Corp. - November 12, 2024) - The law firm of Kirby McInerney LLP reminds investors of the November 29, 2024 deadline to seek the role of lead plaintiff in a federal ...
The law firm of Kirby McInerney LLP is investigating potential claims against ADMA Biologics, Inc. (“ADMA Biologics” or the “Company”) (NASDAQ: ADMA).
The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the District of Maryland on behalf of those who acquired Elanco Animal ...
The law firm of Kirby McInerney LLP is investigating potential claims against ADMA Biologics, Inc. (“ADMA Biologics” or the “Company”) (NASDAQ: ADMA). The investigation concerns whether ...
NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the December 16, 2024 deadline to seek the role of lead plaintiff in a federal securities class ...
The law firm of Kirby McInerney LLP reminds investors of the December 16, 2024 deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of those who ...
Kirby McInerney LLP is a New York-based plaintiffs' law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm's efforts on behalf of shareholders in securities ...
The law firm of Kirby McInerney LLP is investigating potential claims against ADMA Biologics, Inc. (“ADMA Biologics” or the “Company”) (NASDAQ: ADMA). The ...
The law firm of Kirby McInerney LLP reminds investors of the December 16, 2024 deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of those who acquired ...